Cargando…
Treatment of Focal-Onset Seizures in Children: Should This Be More Etiology-Driven?
To accelerate the process of licensing antiseizure medication (ASM) in children, extrapolation of efficacy data for focal-onset seizures from adults to children ≥2 or ≥4 years of age is now accepted. We summarized the efficacy evidence from randomized, controlled trials that was used to grant approv...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940242/ https://www.ncbi.nlm.nih.gov/pubmed/35330806 http://dx.doi.org/10.3389/fneur.2022.842276 |